Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 62.35 -1.84 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.19 | 52 Week High | $8.22 | |||
| Open | $64.76 | 52 Week Low | $3.07 | |||
| Day High | $64.76 | P/E | N/A | |||
| Day Low | $62.22 | EPS | $-1.30 | |||
| Volume | 2,249,456 | |||||
